Overview

Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
This study investigated asthma-related quality of life in Brazilian patients using omalizumab.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Treatments:
Adrenergic Agents
Adrenergic Agonists
Albuterol
Immunoglobulins
Norepinephrine
Omalizumab
Terbutaline